Ghent University Academic Bibliography

1 – 10 of 13

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?q=author%3D%22O'BRIEN%2C+M*%22+or+(type+exact+bookEditor+and+editor%3D%22O'BRIEN%2C+M*%22)&embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

«previous
1
2
next»

2017
- A1
- journalArticle
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial
Corinne Faivre-Finn, Michael Snee, Linda Ashcroft, Wiebke Appel, Fabrice Barlesi, Adityanarayan Bhatnagar, Andrea Bezjak, Felipe Cardenal, Pierre Fournel, Susan Harden, et al. (2017) LANCET ONCOLOGY. 18(8). p.1116-1125 Mark
2016
- A1
- journalArticle
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)
Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, Jessica Menis, Sanjay Popat, Jan Van Meerbeeck UGent, Veerle Surmont UGent, Paul Baas and Mary O'Brien (2016) EUROPEAN JOURNAL OF CANCER. 54. p.35-39 Mark
2015
- A1
- journalArticle
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
Mary ER O'Brien, Rabab Gaafar, Baktiar Hasan, Jessica Menis, Tanja Cufer, Sanjay Popat, Penella J Woll, Veerle Surmont UGent, Vassilis Georgoulias, Ana Montes, et al. (2015) EUROPEAN JOURNAL OF CANCER. 51(12). p.1511-1528 Mark
2014
- A1
- journalArticle
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Hasan Baktiar, Laurent Greillier, Athanasios Pallis, Jessica Menis, Rabab Gaafar, Richard Sylvester, Dean A Fennell, Paul Baas, Veerle Surmont UGent, Jan Van Meerbeeck UGent, et al. (2014) EUROPEAN JOURNAL OF CANCER. 50(16). p.2771-2782 Mark
2013
- A1
- journalArticle
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
Mary ER O'Brien, Rabab M Gaafar, Sanjay Popat, Francesco Grossi, Allan Price, Denis C Talbot, Tanja Cufer, Christian Ottensmeier, Sarah Danson, Athanasios Pallis, et al. (2013) EUROPEAN JOURNAL OF CANCER. 49(13). p.2815-2822 Mark
2012
- A2
- journalArticle
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
Mary ER O'Brien, Jan Van Meerbeeck UGent, Veerle Surmont UGent and Corinne Faivre Finn (2012) EUROPEAN JOURNAL OF CANCER. SUPPLEMENTS. 10(1). p.99-104 Mark
- A1
- journalArticle
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
Jaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, Mary ER O'Brien, Baktiar Hasan, Richard Sylvester, Robin Rudd, Jeremy Steele, Sara Busacca, Camillo Porta, et al. (2012) EUROPEAN JOURNAL OF CANCER. 48(16). p.2983-2992 Mark
2011
- A1
- journalArticle
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer: EORTC 08062
Mary ER O'Brien, Krzystof Konopa, Paul Lorigan, Lionel Bosquee, Ernest Marshall, Frederique Bustin, Sabine Margerit, Christian Fink, Jos A Stigt, Anne Marie C Dingemans, et al. (2011) EUROPEAN JOURNAL OF CANCER. 47(15). p.2322-2330 Mark
2009
- C3
- conference
Response to chemotherapy predicts longer survival in an individual patient meta-analysis of 1205 patients with mesothelioma
DA Fennell, GL Ceresoli, B Castagneto, P Scullin, M O'Brien, M Parker, B Hasan, R Sylvester, R Rudd, J Steele, et al. (2009) JOURNAL OF THORACIC ONCOLOGY. 4(9). p.S347-S348 Mark
2005
- A1
- journalArticle
Cancer-related anemia: Biological findings, clinical implications and impact on quality of life
JU BLOHMER, J DUNST, L HARRISON, P JOHNSTON, D KHAYAT, H LUDWIG, M O'BRIEN, Simon Van Belle UGent and P VAUPEL (2005) ONCOLOGY. 68. p.12-21 Mark

«previous
1
2
next»